Impact of VARIation of OXYdo-reduction Potential in Cardiac Surgery on Post-operative Outcome
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital, Toulouse
About this trial
Observational, prospective, monocentric study conducted in the cardiac surgery department about biological markers to predict the short-term outcome of heart surgery patients.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
None
Trial population
Patients undergoing scheduled cardiac surgery under CEC for coronary bypass surgery with saphenous vein harvesting at Toulouse University Hospital
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Blood and tissue samples
Other interventionBlood samples will be taken from catheters placed for the purpose of surgery (arterial and venous catheters), or during routine venipunctures. (D-1 pre-op). Tissue samples will be taken from surgical waste generated by the surgery. They will therefore not require any additional incisions or surgical procedures.
walking test
Other interventionThe study includes a walking test between D5 and D7.
Treatment groups
120 Participants
are divided into 1 treatment groupGroup A: Scheduled cardiac surgery patients2 interventions
Trial outcomes
Primary outcomes
1
Simplified Gravity Index
severity score used in intensive care to assess the risk of in-hospital mortality. Score from 0 to 163 points (0 is the best possible state of health / 163 is the worst possible state of health )
Time frame
Day 7Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov